Point72 Hong Kong LTD Biogen Inc. Transaction History

Point72 Hong Kong LTD

$1.57 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $1.25 Million - $1.58 Million	5,902 New	5,902 $1.27 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.77 Million - $2.44 Million	-9,074 Reduced 60.11%	6,022 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $937,512 - $1.11 Million	4,999 Added 49.51%	15,096 $3.08 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.89 Million - $2.38 Million	9,758 Added 2878.47%	10,097 $2.13 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $4.93 Million - $6.34 Million	-22,020 Reduced 98.48%	339 $81,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.89 Million - $2.46 Million	6,679 Added 42.6%	22,359 $6.33 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $4.06 Million - $6.5 Million	15,680 New	15,680 $5.43 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $447,028 - $523,719	-1,840 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $434,718 - $654,359	1,840 New	1,840 $451,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $2.04 Million - $2.35 Million	-7,699 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $1.83 Million - $2.42 Million	7,079 Added 1141.77%	7,699 $2.06 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $194,647 - $246,912	-724 Reduced 53.87%	620 $196,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $241,845 - $334,172	1,099 Added 448.57%	1,344 $399,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $53,272 - $59,750	245 New	245 $57,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $27,849 - $30,698	-127 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $27,522 - $43,047	127 New	127 $30,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $26,415 - $34,544	-90 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $75,453 - $89,924	-293 Reduced 76.5%	90 $26,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $99,629 - $140,909	383 New	383 $105,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $29,841 - $33,424	-97 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $27,271 - $31,979	97	97 $30,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Account